Third dose of COVID-19 vaccine does not appear to increase severe adverse events

Investigators report that even though there was some increase in cases of low-severity adverse events after third-dose vaccination against SARS-CoV-2 infection with mRNA vaccines, such third-dose vaccination did not significantly increase severe adverse events. The findings appeared on April 14, 2022 in JAMA Network Open. As background the authors said. “Recent reports on waning of COVID-19 vaccine–induced immunity have led […]

Covid vaccination linked to hair loss

A  report of nine cases of alopecia areata (AA) following SARS-CoV-2 vaccination appears to confirm suspicions that mRNA vaccines can trigger autoimmune responses that lead to hair loss. The nine cases had received either the Pfizer or Moderna SARS-CoV-2 mRNA vaccines and AA was reported from two weeks after the first dose to four months after the second dose. Detailed […]

FDA Advisory Committee unanimously votes in support of emergency use for a booster dose of Moderna’s COVID-19 Vaccine in the U.S

Moderna, Inc. confirmed that the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) recommended that the FDA grant an Emergency Use Authorization (EUA) for a booster dose of the Moderna COVID-19 vaccine (mRNA-1273) at the 50 µg dose level for people aged 65 and older; people aged 18 to 64 who are at high risk of severe COVID-19; and […]